Piero Pollesello
Orion Corporation (Finland)(FI)Orion Corporation (United Kingdom)(GB)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiac electrophysiology and arrhythmias, Cardiovascular Function and Risk Factors, Mechanical Circulatory Support Devices, Cardiac pacing and defibrillation studies
Most-Cited Works
- → Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis(1995)387 cited
- → Noninvasive in vivo quantitative assessment of fat content in human liver(1997)316 cited
- → Levosimendan: Molecular mechanisms and clinical implications(2011)310 cited
- → Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology(2019)280 cited
- → Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology(2018)235 cited
- → Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.